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Production of Ribosome Components
in Effector CD4 T Cells Is Accelerated
by TCR Stimulation and Coordinated by ERK-MAPK
cytokines within hours of subsequent antigen stimula-
tion (Garcia et al., 1999; Rogers et al., 2000). Which
subset of cytokines a particular cell elaborates depends
upon many factors, including the cytokine environment
at the time of antigen encounter, as well as the strength
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Transduction of signals from the cell surface to theSurgeons
701 West 168th Street nucleus is among the better-studied aspects of T cell
molecular physiology. T cell receptor (TCR) engagementNew York, New York 10032
3 Center for Studies in Physics and Biology phosphorylates receptor-proximal tyrosine kinases which
activate phospholipase C (Singer and Koretzky, 2002).The Rockefeller University
1230 York Avenue Signaling then bifurcates into at least two pathways,
one mediated by Ca2 and the other by protein kinaseNew York, New York 10021
C (PKC). Elevation of Ca2 stimulates calcineurin, which
promotes nuclear translocation of the NFAT family of
transcription factors (Rao et al., 1997). PKC activatesSummary
mitogen-activated protein kinases (MAPKs), each of
which has been implicated to varying extents in T cellEffector CD4 T cells rapidly activate high-level cyto-
kine expression following TCR stimulation. Consistent function (Rincon, 2001). Calcium and PKC signaling con-
verge in the nucleus to drive cytokine transcription (Ma-with accelerated protein production in these cells,
global mRNA profiles revealed that, after cytokines, cian et al., 2001).
TCR stimulation also increases cytokine expressionthe most impressive cluster of activated genes encode
rRNA-maturation factors. Activation of these genes via several posttranscriptional mechanisms. Cis-acting
AU-rich sequences in the 3 UTR target many cytokinewas ERK-MAPK dependent, accompanied by in-
creased rRNA transcription and faster maturation ki- mRNAs for rapid degradation by the exosome (Chen et
al., 2001; Stoecklin et al., 2001). Stimulation overridesnetics, and much greater in effector CD4 T cells than
in naive cells. Ribosomal protein subunit (RPS) synthe- these constitutive degradation signals and lengthens
mRNA half-life (Wodnar-Filipowicz and Moroni, 1990).sis was also ERK-MAPK dependent and increased to
match rRNA production, but without evident increase IL-2 mRNA, in addition, possesses 5 cis-acting ele-
ments which stabilize the mRNA in response to JNKin RPS mRNA. Instead, stimulation promoted poly-
some loading of RPS mRNA via cis-acting, 5-terminal activation (Chen et al., 1998). TCR stimulation increases
the translation efficiency of more than 10% of T celloligopyrimidines. These results demonstrate how, in
response to extracellular signals, effector CD4 T cells mRNAs, including some cytokine genes, via differential
loading of mRNA onto polyribosomes (Garcia-Sanz etcoordinately increase multiple ribosomal components
to accommodate burgeoning cytokine production. al., 1998; Mikulits et al., 2000).
Many molecular properties have been identified which
distinguish particular subpopulations of CD4 T cellsIntroduction
(Glimcher and Murphy, 2000). As but one example, CD4
effector T cells may be classified as Th1 or Th2 cellsCD4 T cell differentiation provides a rich model system
for studying molecular mechanisms that underlie devel- depending upon the particular cytokines they elaborate
(Interferon- or IL-4, respectively). Critical transcriptionopmental switches. T cell precursors migrate from the
bone marrow to the thymus where they pass through a factors that are differentially expressed in these cells
have been identified, including T-bet, a Th1-specific fac-series of stages distinguished by differential expression
of a number of markers, including CD4 and CD8, and tor, and the Th2-specific factors, GATA-3 and c-MAF.
clonal selection based on T cell receptor (TCR) specific- With stimulation and polarization toward Th1 or Th2
ity (Berg and Kang, 2001; Marrack and Kappler, 1997). phenotypes, there is differential chromatin remodeling
Naive CD4 T cells exit the thymus and circulate through at the loci encoding the cytokines which define these
the blood, lymph, and secondary lymphoid tissues scan- CD4 subtypes (Agarwal and Rao, 1998; Avni et al.,
ning peptide-MHC complexes displayed on the surface 2002). Th1 and Th2 cells are also differentiated from
of antigen-presenting cells (Mellman and Steinman, each other by differential chemokine receptor expres-
2001). Encounter with antigen in the proper context trig- sion, and these loci are also regulated at the level of
gers cell division and cytokine production, and alters chromatin structure (Scotet et al., 2001).
tissue-homing properties. Maximal cytokine production We used GeneChips to examine the effect of stimula-
is not reached until at least 4 days later (Swain, 1999), tion on global gene expression in Th2-polarized CD4
at which point production tapers off. Cells that receive T cells. Uncharacterized homologs of genes required
appropriate costimulatory signals survive the expansion for rRNA production in yeast were among the most sig-
process and are armed to churn out specialized effector nificantly upregulated transcripts. This finding initiated
experiments presented here which demonstrate how
the translational machinery is coordinately regulated by*Correspondence: jl45@columbia.edu
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extracellular signals to meet the increased demands effector cells (Figure 1F). Also, RRS1 expression in B
cells stimulated to secrete antibody was at least as highimposed by cytokine production in effector CD4 T cells.
as in effector CD4 T cells (data not shown), suggesting
that induction of the rRNA regulatory genes is indeed aResults
specific response of cells with high protein-produc-
tion capacity.Transcriptional Changes Associated with
Stimulation of Effector CD4 T Cells
Naive CD4 T cells were stimulated for 1 week under Elevated RRS1 Induction Is Intrinsic
to Memory CD4 T CellsTh2 polarizing conditions. The global transcriptional re-
sponse of the resulting Th2 effector cells was then char- The greater RRS1 induction by TCR stimulation in Th2
cells than in naive CD4 T cells might be a necessaryacterized by isolating RNA at various times following
secondary stimulation via the TCR (Figure 1A). Labeled adaptation for increased and faster cytokine production
by Th2 effector cells. Alternatively, increased RRS1 tran-cRNA was generated and hybridized to GeneChips that
monitor expression of over 12,000 transcripts. Com- scription might simply be a result of ongoing stimulation,
since ribosome production increases when quiescentpared to the unstimulated condition, 95% of the tran-
scripts changed less than 2-fold at any time after stimu- cells enter the cell cycle (Warner, 1999). To shed light
on this issue, Th2 cells were generated from naive CD4lation, and less than 0.5% were altered by more than
4-fold. As expected for stimulated Th2 effector cells, IL-4 T cells and then washed and cultured for 6 days in the
absence of cytokines or stimulatory antibodies. 30% ofwas the most highly induced gene (30-fold), followed by
IL-9, IL-3, IL-10, IL-13, and IL-5 (Figure 1B and Table the cells died upon withdrawal of these factors (data
not shown), a percentage identical to what others have1). Other families of transcripts that were significantly
altered by stimulation included those involved in nucleo- reported (Hu et al., 2001). The resulting cells took on
the properties of typical resting memory T cell popula-tide metabolism, signal transduction, transcription, and
the stress response (data not shown). tions (Hu et al., 2001): cell size decreased to that of
freshly isolated naive cells, cell surface CD25 expression
was similarly downregulated, and expression of CD11aStimulation of Effector CD4 T Cells Activates
and CD44 was maintained (Figure 2A and data notTranscription of Genes Encoding
shown). In contrast to unrested Th2 cells, phospho-rRNA Processing Factors
ZAP70 and phospho-ERK were undetectable (FiguresAfter cytokine genes, the largest group of genes signifi-
2B and 3B), consistent with the quiescent state of thesecantly upregulated by stimulation were those encoding
cells. As expected for memory Th2 cells, when the restedfactors that modify RNA (Figures 1B and 1C, and Table
cells underwent TCR stimulation these signaling pro-1). Among these were genes encoding RNA splicing and
teins became highly phosphorylated (Figure 2B) andediting factors. Strikingly, six of the GeneChip probes
large quantities of IL-4 were secreted into the mediareporting the greatest increase in expression in re-
(Figure 2C). Whether stimulation was with anti-CD3 anti-sponse to stimulation were EST homologs of the S. cere-
body alone, or with anti-CD3 and anti-CD28 antibodies,visiae genes RRS1, GAR1, NHP2, EBP2, NIP7, and
RRS1 induction was significantly greater in the restedHRAMT. These genes encode nucleolar proteins that
Th2 memory cells than in the naive CD4 T cells (Figurephysically interact with each other and postranscription-
2D). These results indicate that increased RRS1 induc-ally modify rRNA.
tion is a fixed property of memory Th2 cells, independentTranscriptional activation of murine RRS1, GAR1,
of activation state.NHP2, EBP2, NIP7, and HRAMT in response to stimula-
tion was confirmed using real-time RT-PCR (Figure 1D).
Transcription of Dyskerin, a mammalian homolog of a ERK MAPK Activates Transcription of Genes
Encoding rRNA Processing Factorsyeast rRNA regulator (Henras et al., 1998) that was not
probed by the GeneChip, was also increased by stimula- TCR stimulation activates calcium-dependent and PKC-
dependent signaling pathways, both of which are re-tion (Figure 1D). Although expressed in all tissues exam-
ined, these genes were most highly expressed in organs quired for full transcriptional activation of cytokine
genes such as IL-2 (Macian et al., 2001). In contrast,of the immune system where CD4 effector T cells are
located (Figure 1E). pharmacologic activation of the PKC-dependent path-
way alone with PMA was sufficient to fully induce RRS1Steady-state levels of mRNA for RRS1, NIP7, GAR1,
and NHP2 were all coordinately regulated when expres- transcription (Figures 3A and 3B). Accordingly, the non-
specific PKC inhibitor staurosporine completely blockedsion levels were examined in different tissues (Figure
1E and data not shown). RRS1 was therefore selected RRS1 induction via the T cell receptor (Figure 3A).
RRS1 transcription was activated by ionomycin aloneas a model gene for further study of rRNA regulatory
gene transcription. RRS1 was activated by stimulation to a lesser extent than by PMA, and the calcineurin
inhibitor cyclosporine had no effect on induction ofof either Th1 or Th2 biased CD4 T cells, and it was
activated in serum-pulsed, mouse embryonic fibroblasts RRS1 transcription, even at concentrations which com-
pletely blocked activation of IL-2 transcription, Th2 ef-(data not shown), suggesting that transcriptional activa-
tion of the rRNA regulatory genes is responsive to path- fector cell proliferation, and NFAT dephosphorylation
(Figures 3A and 3C and data not shown). These resultsways conserved among these cell types. Nonetheless,
when RRS1 expression levels in naive and Th2 effector indicate that calcium-dependent signaling plays a less
important role than the PKC-dependent pathway in theCD4 T cells were compared, the absolute level, as well
as the magnitude of induction, was much greater in the induction of RRS1 transcription, especially given that
Ribosome Production in CD4 T Cells
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Figure 1. Expression of Genes Encoding rRNA Processing Factors Is Increased by Stimulation of Th2 Effector Cells
(A) In all experiments, Th2 cells were generated from naive CD4 splenocytes and lymph node cells and stimulated via the TCR, as indicated.
The timing of RNA collection for synthesis of GeneChip probes is shown.
(B) Global mRNA expression GeneChip results comparing samples from 0 (y axis) and 4 (x axis) hr after stimulation. Dotted lines demarcate
the region outside of which the log transformed differential expression ratio of a gene is greater than twice the local standard deviation in
the log-ratios. Dark circles pinpoint genes encoding Th2 cytokines; boxes, regulators of rRNA; triangles, ribosomal protein subunits.
(C) GeneChip hybridization data showing fold-increase in expression 4, 8, and 12 hr poststimulation for genes encoding rRNA processing factors.
(D) Real-time RT-PCR data showing fold-increase in expression of rRNA processing factors 4 hr poststimulation.
(E) Quantitation of rRNA processing factor expression, relative to GAPDH, in the indicated organs. Data were quantitated by real-time RT-PCR.
(F) RRS1 mRNA from the indicated cell populations was quantitated using real-time RT-PCR after normalization based on GAPDH mRNA levels.
calcium ionophores activate ERK in a number of differ- had little effect on RRS1 transcriptional activation, even
at concentrations which compromise cell viability, blockent cell types, including primary T and B cells (Atherfold
et al., 1999; Franklin et al., 2000, 1994). Rapamycin also phosphorylation of ribosomal protein S6, and block Th2
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Table 1. Transcripts Upregulated by Stimulation of CD4 Th2 Effector Cells
Hrs Poststimulation
Accession # 4 12 24
Cytokines
Interleukin-4 X03532 29.0 31.0 12.0
Interleukin-9 M30136 6.1 6.4 13.0
Small Inducible Cytokine A3 J04491 4.4 7.1 9.5
Interleukin-2 M16762 6.6 2.5 2.2
Small Inducible Cytokine A1 M23501 1.7 6.6 4.6
Mast Cell Growth Factor (IL-3) K01668 2.4 6.5 1.8
MIP-1b X62502 5.1 3.7 6.3
Granulocyte Macrophage CSF X03020 4.5 6.2 2.7
Preproenkephalin 2 M55181 3.8 5.1 2.9
ETA-1/minopontin X13986 1.7 2.6 5.0
TNF-B M16819 4.6 2.7 2.8
Chemokine ABCD-1 AF052505 1.3 4.6 3.9
Interleukin-10 M37897 4.1 3.2 2.4
Interleukin-13 M23504 3.3 3.1 3.4
Interleukin-5 X06271 2.2 2.2 1.3
RNA Processing Factors
RRS1 AA656775 8.5 4.5 5.8
GAR1 A1851198 7.9 5.6 5.2
GRY-RBP AF093821 6.9 2.7 2.5
EBP2/Nucleolar Protein 40 A1845934 4.1 6.6 4.0
NOLA2/NHP2 AW121031 4.8 5.0 3.7
NIP7 AW123267 5.0 3.0 2.7
Hetero. RNP Arg methyl-transferase A1837110 3.1 2.4 6.3
SIK AF053232 5.4 2.8 3.0
SnRNP Sm D3 AA796831 2.3 4.1 5.4
U6 snRNA-associated, SM-like AW049564 2.7 4.0 3.5
effector cell proliferation (Figures 3A–3C and data not modification and cleavage events undergone by rRNA
precursors that ultimately produce mature 18S, 25S, andshown); this drug inhibits mTOR/FRAP, a serine/threo-
nine kinase that mediates cellular response to mitogens 5.8S rRNAs (Figure 4A). Gar1p, Nhp2p, and Cbf5p (the
yeast homolog of Dyskerin) are components of a nucleo-through signaling to p70s6 kinase and 4E-BP1 (Raught
et al., 2001). lar complex that cleaves rRNA at sites A1 and A2 (Figure
4A) and is required for production of mature 18S rRNATo determine which MAPK pathways are required for
RRS1 transcriptional activation, cells were treated with (Bousquet-Antonelli et al., 1997; Girard et al., 1992; Hen-
ras et al., 1998). RNA binding activity and nucleolar local-specific inhibitors. SB203580, a direct inhibitor of P38
MAPK, had no detectable effect (Figures 3A and 3B). ization of Gar1p is modified by HRAMT (Frankel and
Clarke, 1999; Liu and Dreyfuss, 1995). RRS1, EBP2, andThis result is consistant with the fact that we were unable
to detect phosphorylation of p38, or of JNK, under the perhaps NIP7, constitute a separate complex (Figure
4A), depletion of which blocks 25S and 5.8S rRNA pro-stimulation conditions used here (data not shown).
U0126, an indirect inhibitor of ERK MAPK acting duction (Huber et al., 2000; Tsujii et al., 2000).
To determine if transcriptional activation of rRNA pro-through upstream MEK1 and 2, was effective at blocking
RRS1 activation and Th2 effector cell proliferation (Fig- cessing factor genes has functional consequences, the
effect of TCR stimulation on rRNA transcription and pro-ures 3A and 3C). It also inhibited RRS1 induction with
stimulation of rested Th2 memory cells (Figure 2D). Im- cessing kinetics was examined. First, by radiolabeling
cells with orthophosphate, synthesis of full-length rRNAmunoblot with antibodies specific for phospho-ERK
confirmed that U0126 blocked ERK phosphorylation precursor was demonstrated to be increased 3-fold in
response to stimulation (Figure 4B). Then, to visualizeafter stimulation of either rested or unrested Th2 cells
(Figures 2B and 3B). This result indicates that ERK- short-lived, low-abundance, rRNA processing interme-
diates, a real-time RT-PCR assay was established usingMAPK is required for activation of RRS1 transcription in
stimulated T cells. Interestingly, at 4 hr poststimulation, three sets of primers that amplify across different pre-
cursor cleavage sites (Figure 4A). Product accumulationERK2 was among the most highly upregulated genes
detected by the GeneChip (7-fold increase), suggesting for each set of primers accurately reflected 2-fold serial
dilutions of template (Figure 4C and data not shown),that early transcriptional activation of ERK2 amplifies
PKC signaling to increase expression of genes encoding demonstrating the linear response of this assay. TCR
stimulation caused no detectable change in steady-the rRNA regulators.
state levels of precursor rRNA processing intermediates
(data not shown). This finding, in the face of increasedStimulation of Effector CD4 T Cells Induces rRNA
rRNA transcription (Figure 4B), suggested that precursorTranscription and Accelerates rRNA Processing
processing kinetics was accelerated by TCR stimu-S. cerevisiae homologs of GAR1, NHP2, Dyskerin,
HRAMT, RRS1, EBP2, and NIP7 are essential for various lation.
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Figure 2. RRS1 mRNA Induction Is Greater in Resting Th2 Memory Cells Than in Naive CD4 T Cells
(A) Cell surface CD25 expression on Th2 effector cells after 1 week of stimulation (1 Stim), on memory Th2 cells that had been washed and
cultured without cytokines or stimulation for 6 days (Rested), or on the rested memory Th2 cells after restimulation (2 Stim).
(B) Western blots for the indicated proteins using lysates from naive CD4 T cells or memory Th2 cells that had been stimulated as indicated.
(C) IL-4 secretion by the indicated cell populations.
(D) RRS1 mRNA from the indicated cell populations was quantitated using real-time RT-PCR after normalization based on GAPDH mRNA levels.
To examine the effect of TCR stimulation on rRNA rRNA processing rates was not observed at 24 hr post-
stimulation (data not shown), suggesting that mecha-processing rates, transcription was blocked with actino-
mycin, and the rate of disappearance of rRNA precursor nisms for increasing the rate of rRNA cleavage were
completely downregulated by this time.species was determined by quantitating the steady-
state levels of rRNA precursor that remained over time.
Th2-differentiated CD4 T cells were either rested or Ribosomal Protein Synthesis Increases
in Response to T Cell Stimulationstimulated via the TCR for 8 hr, and nuclear RNA was
harvested at various times after actinomycin addition If the number of functional ribosomes increases in re-
sponse to TCR stimulation, then RPS production must(Figure 4D). At the initital time point, amplification plots
for resting and stimulated T cells were identical, indicat- increase concomitant with the acceleration in rRNA pro-
duction (Warner, 1999). To examine RPS production,ing that the initial quantity of precursor was the same
in both cell populations. Though all rRNA precursor spe- effector CD4 T cells were lysed in hypotonic solution,
nuclei and mitochondria were removed by centrifuga-cies, whether in stimulated or unstimulated cells, were
less than 5% of starting levels by 45 min after actinomy- tion, and ribosomes were accelerated through 2M su-
crose. Enrichment of ribosomes in this fraction was con-cin addition, processing kinetics at the A1 and A2 sites
was significantly accelerated by stimulation, with decay firmed by Western blot with antibodies specific for either
of two RPSs, RPL7A or RPL13A (Figure 5A). The ribo-rates roughly four times faster than in unstimulated cells
(Figure 4D). In contrast, decay of the A0 product pro- some enrichment method was then used to visualize
newly synthesized proteins by SDS-PAGE after meta-ceeded at approxiately the same rate in stimulated and
unstimulated cells, indicating that factors required for bolic-labeling with 35S-cysteine and methionine. The sig-
nal intensity of discrete, relatively low-molecular weightcleavage at this site were not altered by stimulation.
Thus, T cell stimulation increased rRNA processing ki- proteins, characteristic of RPSs enriched using this
method (Nadano et al., 2000), increased after TCR stimu-netics at the specific precursor cleavage sites targeted
by factors that had been transcriptionally upregulated lation (Figure 5B), an effect that was blocked by cyclo-
heximide (Figure 5B). In complementary experiments,in response to stimulation. A significant difference in
Immunity
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Figure 3. RRS1 mRNA Increases in Re-
sponse to ERK-MAPK Signaling
(A) Th2 effector CD4 T cells were incubated
in inhibitors for 90 min, and then stimulated
for 4 hr. RRS1 mRNA was quantitated by real-
time RT-PCR after normalization based on
GAPDH mRNA levels.
(B) Th2 effector CD4 T cells were incubated
in inhibitors for 30 min, and then stimulated
for 15 min. Cells were lysed and probed in Im-
munoblots.
(C) Th2 effector CD4 T cells were incubated
in inhibitors for 30 min, stimulated for 24 hr,
and then pulsed with 3H-thymidine. After 16
hr, 3H-thymidine incorporation was mea-
sured.
effector CD4 T cells were metabolically labeled and sequences which posttranscriptionally increase expres-
RPL13A was immunoprecipitated; synthesis of this RPS sion in response to increased metabolic demand by
increased approximately 4-fold in response to TCR stim- promoting polysome loading (Meyuhas, 2000). To study
ulation (Figure 5C). Thus, TCR stimulation increased TOP-directed, posttranscriptional regulation of RPS
RPS synthesis to an extent that was comparable to the synthesis in stimulated effector CD4 T cells, a GFP-
increase in rRNA transcription and processing (compare reporter was constructed using the well-characterized
with Figure 4B). promoter and TOP-containing 5-UTR of RPS16 (Hari-
haran and Perry, 1989, 1990; Levy et al., 1991). To permit
efficient delivery to primary T cells, the RPS16-GFP re-ERK MAPK Signaling Increases Translation
porter was cloned into a retroviral vector based on theof Oligopyrimidine-Containing RPS mRNA
murine stem cell virus (Figure 5D). The 3 LTR enhancerNone of 32 RPS mRNAs probed on the GeneChip in-
was deleted so that the viral promoter resulting fromcreased as much as 2-fold in response to TCR stimula-
retroviral transduction into target cells would not inter-tion (Figure 1B). This is consistent with the fact that
RPS mRNAs possess 5 terminal oligopyrimidine (TOP) fere with RPS16-reporter expression (Figure 5D). To fa-
Ribosome Production in CD4 T Cells
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Figure 4. Stimulation Increases rRNA Transcription and Precursor Processing Kinetics in Th2 Effector Cells
(A) Schematic diagram showing rRNA precursor processing. A0, A1, and A2 are processing cleavage sites monitored by real-time RT-PCR in
experiments below. ETS, external transcribed spacer; ITS, internal transcribed spacer.
(B) Precursor rRNA synthesis in Th2 cells is increased by stimulation, as monitored by incorporation of radioactive orthophosphate. Samples
were normalized using mature rRNA.
(C) Real-time RT-PCR standard curve generated using primers spanning the A1 cleavage site and 2-fold serial dilutions of a cloned amplicon
as template (in duplicate). The cycle number at the product detection threshold (using SYBR green) is plotted versus the template dilution
factor in the inset. A similar linear relationship (R  0.998) was demonstrated with standard curves for primers spanning the A0 and A2
cleavage sites.
(D) Nuclear RNA was harvested from Th2 cells (stimulated or unstimulated) after incubation for the indicated times in actinomycin D. Plots
show the fraction of precursor remaining, as detected by real-time RT-PCR using primers spanning the A0, A1, or A2 cleavage sites.
cilitate quantitation of reporter protein induction, GFP trifuged onto target cells, 90% of the population was
reproducibly rendered GFP-positive, as determined bywas expressed as a fusion to a PEST degradation signal,
reducing the half-life of GFP from 24 hr to 4 hr (data not flow cytometry (Figure 6 and data not shown). One week
following primary stimulation, the effect on reporter ex-shown). Two additional retroviruses were engineered for
control experiments (Figure 5D). The first expressed the pression of secondary stimulation with anti-CD3 anti-
body was examined. As compared to unstimulated cells,reporter from the RPS16 promoter but lacked the TOP-
containing RPS16 5UTR. The second replaced the secondary stimulation for 6 hr increased steady-state
levels of GFP-PEST more than 4-fold, whether moni-RPS16 promoter and 5UTR sequence with the constitu-
tive cyclophilin A promoter. tored by Western blot (Figure 5E) or by flow cytometry
(Figure 6C).Naive CD4 T cells, stimulated with anti-CD3 and anti-
CD28 antibodies under Th2-biased conditions, were in- The majority of the increase in protein synthesis was
due to posttranscriptional mechanisms since stimula-fected with RPS16-TOP reporter retrovirus. After two
sequential infections in which virion particles were cen- tion had minimal effect on steady-state mRNA levels for
Immunity
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Figure 5. Stimulation of Th2 Effector Cells Increases RPS Translation
(A) Ribosome enrichment demonstrated by RPL7A and RPL13A immunoblots. P, pellet; S, supernatant.
(B) Effect of stimulation and the indicated drugs on metabolic labeling of ribosomal proteins, enriched as in (A). Cyclophilin A (CypA) immunoblot
as loading control.
(C) Effect of stimulation on synthesis of RPL13A, detected by metabolic labeling and immunoprecipitation.
(D) Retroviral vectors used to transduce primary CD4 T cells. GFP half-life was decreased by fusion to a PEST sequence. A deletion in the
viral enhancer (U3) minimized interference from proviral transcription. Reporter expression from the first vector (RPS16-TOP) is under the
control of the RPS16 promoter and TOP-containing RPS16 5UTR. The second vector has RPS16 5UTR sequences removed (RPS16-TOP).
In the third vector, the RPS16 promoter and 5UTR have been replaced with the murine cyclophilin A promoter.
(E) RPS16-TOP reporter protein 6 hr after stimulation. Immunoblot for GFP protein (upper panel) and for the endogenous cellular protein
cyclophilin A.
(F) Steady-state RPS mRNA is not increased by stimulation of Th2 cells. Endogenous RPS16 mRNA from untransduced Th2 cells was
quantitated by real-time RT-PCR. RPS16-TOP reporter RNA from transduced Th2 cells was quantitated by the same method. Where indicated,
brefeldin A was added prior to stimulation.
(G) RPS16 mRNA shifts to polysome fractions in response to TCR stimulation of CD4 Th2 cells. Shown is real-time RT-PCR quantitation of
the indicated RNAs contained within each fraction harvested from a 15%–40% linear sucrose gradient. Stimulation was for 4 hr.
(H) eIF2 phosphorylation in Th2 memory cells in response to stimulation and the indicated drugs. Immunoblot was stripped and reprobed
with anti-eIF2 antibody.
Ribosome Production in CD4 T Cells
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Figure 6. Induction of RPS16-TOP Reporter
Expression by Stimulation of Th2 Effector
Cells Is Largely Posttranscriptional and ERK-
MAPK Dependent
CD4 T cells were transduced with retroviral
vectors in which GFP-PEST-reporter expres-
sion was driven by either the murine cyclophi-
lin A promoter (A), the murine RPS16 pro-
moter with no RPS16 5-UTR (B), or the
RPS16 promoter with an intact TOP-con-
taining 5-UTR (C–L). GFP fluorescence inten-
sity was monitored by flow cytometry. The
dark tracing with no shading under the curve
shows expression in unstimulated cells (A–C)
or in cells stimulated in the presence of the
indicated drugs (D–L). The lighter tracing with
shading under the curve shows the effect of
stimulation in the absence of the drug. Some
experiments were performed with a common
no drug control, which is repeated in each
panel to aid interpretation of the data.
either GFP-PEST expressed from the retroviral vector As demonstrated with transcriptional induction of the
ribosomal regulatory genes (Figure 3A), activation of theor endogenous RPS16 mRNA (Figure 5F). Consistent
with this, actinomycin had minimal effect on reporter PKC pathway by PMA was sufficient to fully induce
RPS16-TOP reporter activity (Figure 6F). Staurosporineinduction (Figure 6D). Rather than increase the half-
life of GFP-PEST, stimulation probably increased new and U0126 inhibited induction by TCR stimulation (Fig-
ures 6G and 6H), suggesting that the ERK MAPK path-protein synthesis since cycloheximide completely blocked
induction (Figure 6E), the half-life of GFP-PEST in the way was responsible for much of the induction. CsA had
no effect on reporter induction (Figure 6I), indicating thatpresence of cycloheximide was unchanged by stimula-
tion (data not shown), there was minimal effect of stimu- calcineurin-dependent pathways were not required for
induction of RPS expression.lation on expression of the identical GFP reporter from
the cyclophilin A promoter (Figure 6A) or from the RPS16 Previous reports indicated a correlation between
RPS-S6 phosphorylation and the efficiency of TOP-promoter with a deletion in the 5UTR TOP sequence
(Figure 6B), and the magnitude of the increase corre- dependent translation (Jefferies et al., 1997). By blocking
the TOR signaling pathway, rapamycin inactivates thesponded to the magnitude increase in synthesis of en-
dogenous RPS protein, as determined by metabolic la- p70s6 kinase (Raught et al., 2001) and has been reported
to inhibit translation of 5TOP sequences (Jefferies etbeling (Figure 5C). Finally, it was shown that, in response
to stimulation of primary CD4 Th2 effector cells, there al., 1994). In agreement with more recent studies (Stolov-
ich et al., 2002; Tang et al., 2001), we saw only minimalwas a pronounced shift of endogenous RPS16 mRNA
from low-density to high-density subcellular fractions, effect of Rapamycin on TOP-reporter expression (Figure
6J), and strong blockade by the PI3-kinase inhibitorconsistent with activation-induced loading of this mRNA
onto polysomes (Figure 5G). In contrast to this effect of LY294002 (Figure 6K).
By blocking protein secretion, brefeldin activates astimulation on RPS16 mRNA, GAPDH mRNA was consti-
tutively associated with polysomes (Figure 5G). stress response which phosphorylates eIF2 and ar-
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rests translation (Mellor et al., 1994). Brefeldin treatment four proteins belong to a functional unit and physically
interact with each other.of either naive CD4 T cells or Th2 memory cells caused
increased phosphorylation of eIF2, whether cells had GAR1, NHP2, RRS1, EBP2, NIP7, HRAMT, and Dys-
kerin, a group of genes previously uncharacterized inbeen stimulated via the TCR or not (Figure 5H). Brefeldin
also blocked expression of the retroviral GFP reporter mammals, were among the mRNAs with the largest mag-
nitude increase in response to TCR stimulation (Figure(Figures 5D and 6B) in which TOP sequences had been
deleted (data not shown). In stimulated effector CD4 1B and Table 1). This expression profile, along with the
data on rRNA precursor processing kinetics (Figure 3),T cells, ERK or PI3-kinase might counteract a similar
stress-response that is activated by high-level cytokine suggest that these genes be added to the list of factors
regulating mammalian rRNA precursor processing. Pro-expression. We were unable to detect a clear effect of
these signaling pathways on eIF2 phosphorylation or cessing kinetics at the A1 and A2 cleavage sites, and not
at the A0 site, was dramatically accelerated followingon the expression of the retroviral GFP reporter lacking
TOP sequences (data not shown). Taken together, these T cell stimulation (Figures 4A and 4D), as would be pre-
dicted by the yeast literature for upregulation of thesedata suggest that ERK and PI3-kinase pathways have
specific effects on TOP-dependent polysome loading. factors (Bousquet-Antonelli et al., 1997; Girard et al.,
1992; Henras et al., 1998). To our knowledge, this is the
first demonstration of regulated processing of mamma-
Discussion lian rRNA.
Here, we demonstrated that, in concert with increased
RPS Expression in T Cells Is Regulated
cytokine expression, TCR stimulation of CD4 effector
at the Level of Translation
T cells rapidly accelerates ribosome production. This
In yeast, nutrients stimulate transcription of both rRNA
complex developmental program is characterized by
and ribosomal protein components, despite the fact that
increased transcription of rRNA and of a family of genes
these two classes of genes are transcribed by different
encoding rRNA processing factors, by increased rRNA
RNA polymerases (Warner, 1999). Transduction of the
precursor processing kinetics, and by increased transla-
nutrient signal occurs through both a ras-cAMP pathway
tion of RPS mRNA. Evidence was provided that both
and a TOR-dependent pathway (Warner, 1999). The co-
transcriptional and posttranscriptional responses are
ordinate regulation of ribosomal protein and rRNA ob-
ERK-MAPK dependent.
served in yeast holds true for effector CD4 T cells,
but with an important qualification: RPS synthesis is
regulated at the translational level (Figures 5 and 6).Function of rRNA Precursor Processing Factors
Regulated translation of RPSs has been observed inIn S. cerevisiae, GAR1, NHP2, Dyskerin, and a fourth
lymphosarcoma cells treated with dexamethasoneprotein, NOP10, complex with the H box/ACA class of
(Meyuhas et al., 1987), during Xenopus embryogenesissmall nucleolar RNAs (snoRNAs) and guide pseudouri-
(Pierandrei-Amaldi et al., 1985), in regeneration of par-dylation of rRNA (Girard et al., 1992). This rRNA modifica-
tially lobectomized liver (Aloni et al., 1992), and upontion is hypothesized to influence RNA folding (Charette
response to insulin (DePhilip et al., 1980). In these exper-and Gray, 2000). Depletion of Gar1p or Nhp2p in S.
imental systems, as in ours, association of RPS mRNAscerevisiae, in addition to disrupting pseudouridylation,
with polysomes is increased in response to stimulationblocks early rRNA cleavage steps and 18S rRNA synthe-
(Meyuhas, 2000).sis (Bousquet-Antonelli et al., 1997). By altering rRNA
structure, GAR1-NHP2-mediated pseudouridylation might
render the rRNA precursor accessible to nucleases. Mu- Signaling Pathways Regulating Ribosome Synthesis
Growth factors stimulate ERK-dependent phosphoryla-tants of EBP2, RRS1, and NIP7 are defective in synthesis
of 28S RNA (Huber et al., 2000; Tsujii et al., 2000; Tsuno tion of the transcription factor UBF (Stefanovsky et al.,
2001). This results in a 2.5-fold increase in 45S rRNAet al., 2000), but unlike GAR1 and NHP2, these proteins
have not been implicated in biochemical modification synthesis peaking within 30 min, and subsiding com-
pletely by 24 hr. We observed a similar magnitude andof rRNA.
Functional evidence for mammalian factors which cat- time course in stimulation of rRNA synthesis following
T cell activation (Figure 4B). This observation was ex-alyze distinct rRNA processing steps has lagged behind
studies in yeast. Nucleolin is important for early cleavage tended further by showing that ERK promotes transcrip-
tion of rRNA processing factors (Figure 3). Thus, rRNAof the 45S precursor (Ginisty et al., 1998) at a site approx-
imating A0 in yeast (Figure 4A). Like Gar1p, nucleolin transcription and processing are both responsive to the
same pathway. Additionally, ERK2 itself was one of thehas a glycine-arginine rich domain, which catalyzes
cleavage of the 5 externally transcribed spacer in vitro. genes most highly upregulated in response to T cell
stimulation.Also like GAR1, nucleolin interacts with snoRNAs, al-
though not of the H/ACA class. Perhaps nucleolin influ- In mammalian cells, it has been reported that rapa-
mycin specifically inhibits translation of mRNAs con-ences folding of nascent rRNA, and thereby recruits
cleavage factors (Ginisty et al., 1998; Tuteja and Tuteja, taining 5TOP sequences (Jefferies et al., 1994). Rapa-
mycin blocks the TOR signaling pathway and inactivates1998). Overexpression of mutant Bop1 in fibroblasts re-
sults in failure of cells to produce 28S or 5.8S rRNA, the p70s6 kinase (Raught et al., 2001). Interestingly, in
yeast, rapamycin also disrupts ribosome synthesis butleaving 18S intact (Strezoska et al., 2000). This pheno-
type is reminiscent of what is observed with yeast de- by blocking rRNA and RPS transcription (Warner, 1999).
Others studying mammalian systems have failed to seepleted for RRS1, NIP7, or EBP2, suggesting that these
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cycloheximide, SB203580, or LY294002 from Calbiochem; rapa-this effect of rapamycin, or of the pathways it regulates,
mycin from Wyeth Labs; or cyclosporine (Sandimmune) from No-on 5TOP-dependent responses (Stolovich et al., 2002;
vartis.Tang et al., 2001). We saw minimal effect of rapamycin
on our TOP-reporter (data not shown). In addition, rapa-
cRNA Preparation for GeneChip Expression Profiles
mycin inhibits T cell proliferation by blocking IL-2 signal- 10 g total RNA (RNeasy, Qiagen) was used as template for reverse
ing (Brennan et al., 1999), and anti-IL2 antibody had transcription using Superscript II (GIBCO) and a primer that appends
a T7 phage promoter, GGCCAGTGAATTGTAATACGACTCACTATAno effect on stimulation-dependent upregulation of our
GGGAGGCGG-(dT)24. Product from the second-strand synthesisreporter (data not shown). These findings indicate that
(Superscript Choice, GIBCO) was used as template for T7 transcrip-TOR signaling is unnecessary for TOP-dependent in-
tion (ENZO BioArray), and 20 g of resulting biotin-labeled cRNAcrease in RPS translation in T cells. Instead, our data
was incubated in fragmentation buffer (40 mM Tris-acetate [pH 8.1],
indicate that TOP-dependent polysome loading in 100 mM KOAc, 30 mM MgOAc) for 35 min at 94C and purified
T cells is ERK dependent, and, as previously reported, of unincorporated nucleotides using G-25 Sephadex (Boeringer).
Labeled, fragmented cRNA was hybridized to U74A mouse genePI3-kinase dependent (Stolovich et al., 2002; Tang et
chips (Affymetrix).al., 2001).
Pharmacologic or genetic blockade of secretion in S.
Analysis of cRNA Hybridization Datacerevisiae inhibits transcription of rRNA and RPS mRNA
Differential expression ratios, data normalization, and estimation of
(Mizuta and Warner, 1994). RRS1, one of the rRNA regu- confidence levels were calculated from the raw GeneChip hybridiza-
lators transcriptionally activated by stimulation in CD4 tion data (.CEL files) as previously described (Naef et al., 2002). The
effector T cells, was first identified in a screen for sup- method applies normalization of the expression levels that accounts
for intensity-dependent trends (Yang et al., 2002). Significance ofpressors of this feedback loop (Tsuno et al., 2000). To
regulation was inferred from a robust estimate of the intensity-determine if the same feedback loop exists in CD4
dependent variance in the log-ratios. In Figure 1B, the curved linesT cells, the effect of pharmacological inhibitors of secre-
delimit the 95% confidence regions for significant regulation.
tion was examined. Brefeldin A, an inhibitor acting at
the level of the endoplasmic reticulum, potently inhibited Generation of RT-PCR Templates
induction of the RPS16-TOP reporter (Figure 6L), or the 2 	 106 T cells were lysed in RLN buffer (50 mM Tris-HCl [pH 8.0],
synthesis of endogenous RPSs (Figure 5B). Identical 140 mM NaCl, 1.5 mM MgCl2, 0.5% NP-40) for 5 min on ice, and
spun in a microfuge at 2000 rpm for 5 min. mRNA was purified fromresults were obtained with monensin, an inhibitor that
cytosolic supernatant (RNeasy, Qiagen); samples were treated withacts at the level of the trans-Golgi (data not shown).
RNase-free DNase (Qiagen) while on the column and a second timeReporter transcript though was unaffected by treatment
after elution. For analysis of rRNA, pellets containing nuclear RNA
with brefeldin (Figure 5F), indicating that, unlike yeast, were washed once with RLN buffer to remove cytosolic contami-
inhibition of RPS synthesis by blockade to secretion nants and RNA was extracted (RNeasy, Qiagen). Whole organ mRNA
was occurring at the posttranscriptional level, almost came from 10-week-old mice. 50–100 mg of minced tissue was
suspended in Trizol (GIBCO), further dissociated by centrifugationcertainly by activating the ER-stress response and phos-
through a Qiashredder (2 min, full speed), extracted using Trizol,phorylating eIF2 (Patil and Walter, 2001). Attempts to
and then purified further using the Qiagen RNeasy mini-kit. 2 mg ofdetermine if retroviral transduction of an RRS1 trunca-
total RNA was used for reverse transcription. cDNA was made using
tion mutant would suppress a putative feedback loop, random hexameric primers and Superscript II (GIBCO); every sample
as it does in yeast, were unsuccessful; viability of the had a control in which no RT was added.
T cells expressing truncated RRS1 was greatly reduced
(data not shown). In addition, brefeldin had no effect on Real-Time PCR
PCR products (35 cycles: 94C, 30 s; 60C, 30 s; 72C, 30 s) wereERK-phosphorylation or on the induction of the ERK-
generated and quantitated using an ABI Prism 7700 Sequence De-dependent genes, RRS1, GAR1, and NIP7 (data not
tector (PE Biosystems). Products were detected using SYBR Greenshown).
(Molecular Probes, 1:100,000) and quantitated by comparison to
standard curves generated by serial-dilution of plasmid containing
the relevant amplicon. In addition, samples were normalized usingExperimental Procedures
GAPDH, since our GeneChip data demonstrated that steady-state
levels of this mRNA were unchanged by stimulation (data notCD4 T Cell Purification, Stimulation, and In Vitro Differentiation
shown). All reactions were performed in duplicate and had controlsNaive CD4 spleen and lymph node cells were isolated from 6- to 12-
in which no RT was added. Final reaction products were verifiedweek-old 129/SvEv mice by sequential enrichment using magnetic
by electrophoresis on agarose gels. For PCR primers see Supple-beads conjugated with anti-CD4 antibody (Dynal), followed by anti-
mental Table S1 at http://www.immunity.com/cgi/content/full/19/4/CD62L antibody (Miltenyi). Final populations were typically 98%
535/DC1.CD4 and90% CD62LHI, as monitored by flow cytometry. Antibod-
ies and cytokines used for stimulation, differentiation, and charac-
terization were purchased from Pharmingen. CD4/CD62LHI cells Western Blots
Tissue samples were homogenized mechanically, suspended inwere suspended at 1.0 	 106/ml in RPMI, 10% fetal calf serum,
0.2% glucose, 100 IU/ml penicillin, 100 mg/ml streptomycin, 2 mM RIPA buffer, and sonicated. Protein concentration was measured
using the BCA Protein Assay Reagent (Pierce). For phospho-proteinglutamine, 
-mercaptoethanol (0.7% vol/vol), and 20 U/ml murine-
IL-2, and added to 24-well plates precoated with 5 g/ml anti-CD3 Westerns, Th2-differentiated cells were stimulated with anti-CD3
antibody or PMA for 15-30. As indicated, prior to stimulation, cellsantibody and 5 g/ml anti-CD28 antibody. For in vitro Th2 biasing,
media were supplemented with anti-mouse-IFN at 4 g/ml and were preincubated for 30 in U0126, rapamycin, or SB20380. Cells
were lysed in RIPA buffer and 5 	 106 cells were loaded per well.1000 U/ml recombinant mouse IL-4; for Th1 biasing, anti-mouse
IL-4 at 4 g/ml and 5 ng/ml recombinant mouse IL-12 were used. Primary antibodies included anti-cyclophilin A (Biomol), anti-RPL7a
and RPL13a (from Taka-Aki Sato), anti-GFP (from Pam Silver), anti-After 1 week, cells were washed and either immediately stimulated
again in 24-well plates precoated with 5 g/ml anti-CD3 antibody ZAP70 (Pharmingen), and antibodies against Erk, phospho-Erk,
JNK, phospho-JNK, p38, and phospho-p38, S6, phospho-S6, eIF2,or rested in media for 6 days. As indicated, cells were treated with
ionomycin, phorbol myristic acetate, brefeldin A, or actinomycin phospho-eIF2, and phospho-Tyr319-ZAP70 (Cell Signaling Tech-
nologies).from Sigma; U0126 or PD98059 from Cell Signaling Technology;
Immunity
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Metabolic-Labeling of Ribosomal Proteins (RNA clean-up protocol), with on-column DNase treatment. Samples
were reverse-transcribed using Superscript II (Invitrogen), and real-Cells were washed and incubated for 30 min in serum-free, methio-
nine-free RPMI (Cellgro). Cells were washed again and resuspended time PCR performed on ABI Prism Sequence Detector 7700 using
primers for RPS16, GAPDH, and sequences internal to the 28S ribo-at 1 	 107 cells/ml in serum-free, methionine-free medium supple-
mented with 100 mCi/ml 35S-labeled methionine/cysteine (Easy Tag somal RNA (as described above).
EXPRESS, NEN). To assay total ribosomal proteins, cells were incu-
bated 90 min in labeling medium, chased 30 min, and lysed in 50 Proliferation Assays
mM Tris-HCl (pH 7.5), 5 mM MgCl2, 25 mM KCl, and 0.2 M sucrose. 5 	 105 Th2-differentiated cells were plated in 200 L and incubated
Lysates were cleared of nuclei and mitochondria by centrifugation for 30 min with either rapamycin, CsA, U0126, or no drug. Cells were
(12,000 	 g for 15 min) and then layered over 50 mM Tris (pH 7.5), then stimulated with PMA or anti-CD3 for 24 hr. 1 uCi of 3H-thymidine
5 mM MgCl2, 25 mM KCl, 2 M sucrose. Ribosomal proteins were was added to each well and incorporation was measured at 16 hr.
recovered from the pellet after centrifugation for 24 hr at 100,000 	
g. For specific ribosomal proteins, cells were labeled 4 hr without Acknowledgments
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